Form 4: Bio-Rad Laboratories Director Receives Stock Grant
Insider Transaction (Form 4)
Schwartz Allison, a Director of Bio-Rad Laboratories, Inc., reported multiple transactions in common stock on September 4, 2026.
Summary
- Option exercise/conversion: acquired 228 Bio-Rad A Common Stock on September 5, 2026; holds 1,758 after (Direct).
- Tax/exercise-price withholding: disposed of 82 Bio-Rad A Common Stock at $386.11 ($31,661) on September 5, 2026; holds 1,676 after (Direct).
- Option exercise/conversion: acquired 92 Bio-Rad A Common Stock on September 6, 2026; holds 1,768 after (Direct).
- Tax/exercise-price withholding: disposed of 34 Bio-Rad A Common Stock at $386.11 ($13,128) on September 6, 2026; holds 1,734 after (Direct).
- Grant/award: acquired 719 Restricted Stock Units on September 4, 2026; holds 719 after (Direct).
- Option exercise/conversion: disposed of 228 Restricted Stock Units on September 5, 2026; holds 686 after (Direct).
- Option exercise/conversion: disposed of 92 Restricted Stock Units on September 6, 2026; holds 185 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Schwartz Allison — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-05 | Option exercise/conversion | Bio-Rad A Common Stock | 228 | — | — | 1,758 |
| 2026-09-05 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 82 | $386 | $31.7K | 1,676 |
| 2026-09-06 | Option exercise/conversion | Bio-Rad A Common Stock | 92 | — | — | 1,768 |
| 2026-09-06 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 34 | $386 | $13.1K | 1,734 |
| 2026-09-04 | Grant/award | Restricted Stock Units | 719 | — | — | 719 |
| 2026-09-05 | Option exercise/conversion | Restricted Stock Units | 228 | — | — | 686 |
| 2026-09-06 | Option exercise/conversion | Restricted Stock Units | 92 | — | — | 185 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-05 | Option exercise/conversion (228 shares) |
| 2026-09-05 | Tax/exercise-price withholding (82 shares) |
| 2026-09-06 | Option exercise/conversion (92 shares) |
| 2026-09-06 | Tax/exercise-price withholding (34 shares) |
| 2026-09-04 | Grant/award (719 shares) |
| 2026-09-05 | Option exercise/conversion (228 shares) |
| 2026-09-06 | Option exercise/conversion (92 shares) |
Keywords
insider transaction, Form 4, BIO BIO.B, BIO-RAD LABORATORIES, INC., neutral, Schwartz Allison
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.